Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
CEO: Selling US Toy allows family owners to refocus on innovative early childhood learning tools
Selling the family-owned US Toy business — a brand that became a household name over its 70-year run — allows its third-generation ownership to shift their full attention to a sister company that serves the early childhood industry with STEM resources, classroom furniture, playground equipment, and more, said Seth Freiden. Constructive Playthings, led today by…
Biotech startup’s latest partnership gets its UniPen into the hands of more pharmacists
A new strategic partnership for Love Lifesciences is expected to leverage its core product — a safe, self-administered injection medication delivery system — to new groups of like-minded, innovation-first companies, said Nick Love. The Overland Park biotech startup on Wednesday announced the deal with the Alliance for Pharmacy Compounding (APC), a leading trade organization, to…
Una Mas Empanadas folds authentic Argentinian flavors into new restaurant spot at Parlor
Expanding Silvia Herrera’s business from a food truck in Gardner to one of Kansas City’s most active and eclectic food hubs brings the Buenos Aires-born entrepreneur — and her grandmother’s 50-year-old handcrafted empanada recipe — to an even wider, more diverse audience, she said. “Our empanadas are more than just food,” Herrera said. “They represent…
It’s not too late to preserve KC’s Black-owned restaurants (or to enjoy Black Feast Week)
The recent closures of Soiree, The Krave, and Privee — Black-owned restaurants that each became a staple of Kansas City’s evolving food scene — leave a clear void that can’t be ignored, said Ryan Sorrell. An initiative to help save local culinary should-be hotspots in similar danger wraps this week, but the work to promote and…